ReviewClinical drug investigation2026

Desvenlafaxine as a Potential First-Line Treatment for Major Depressive Disorder: A Comprehensive Review and Consensus-Based Clinical Perspective on Efficacy, Safety and Patient Selection Profiles.

Claudia Carmassi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.